DOCSLIB.ORG

Optical & Eyewear Sector

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Optical & Eyewear Sector INDEPENDENT RESEARCH Optical & Eyewear Sector 24th June 2015 Confluence of favourable factors in the optical sector! Optical & Eyewear Sector ESSILOR BUY FV EUR124 We maintain our ‘buy’ rating and our FV for EI (EUR124) and LUX Bloomberg EF FP Reuters ESSI.PA (EUR63), although with a slight preference for EI given its upside Price EUR106,25 High/Low 114,9/71,49 potential (+17%). We upgrade SFL from ‘neutral’ to ‘buy’ with an FV of Market cap. EUR22,825m Enterprise Val EUR24,419m PE (2015e) 28.0x EV/EBIT (2015e) 19.8x EUR15 as we expect a gradual improvement in the momentum. Of note, 2016e PEG ratios for EI (1.6x) and LUX (1.7x) are more LUXOTTICA BUY FV EUR63 Bloomberg LUX IM Reuters LUX.MI attractive than in June 2014 thanks to accelerated organic growth and, Price EUR60,15 High/Low 61,85/35,7 more importantly, currency impact! Despite the impact from Gucci in Market Cap. EUR28,827m Enterprise Val EUR29,860m 2017, SFL exhibits a 2016e PEG ratio of 1.2x. PE (2015e) 32.8x EV/EBIT (2015e) 20.6x An exceptionally favourable combination of positive factors in the BUY vs. SAFILO FV EUR15 optical sector! While the companies in our coverage universe already NEUTRAL Bloomberg SFL IM Reuters SFLG.MI enjoyed excellent fundamentals and the optical sector showed strong Price EUR12,91 High/Low 16,35/9,13 structural catalysts, it is now among the major beneficiaries of a weaker Market Cap. EUR810m Enterprise Val EUR946m PE (2015e) 17.9x EV/EBIT (2015e) 10.1x euro, as demonstrated by the impact on Q1 sales (LUX: +14.6%, EI: +12.7% and SFL: +9.8%). Price and data as at close of 19th June 2015-2017: almost all the signals are on green for EI and LUX. They intend to step up growth during the period 2014-17 (CAGR: 11.1%e, EI+LUX average) as they own industry leading brands (Ray-Ban, Varilux…), increase marketing expenses to stimulate demand in mature countries, and expand quickly in emerging markets. This growth will be profitable as we expect a 14.8% CAGR (EI+LUX average) over the period, fuelled by operating leverage, productivity gains and by the rising 23/06/15 127 contribution of the sunglasses and online segments for EI. 122 Safilo: towards more enabling conditions in the coming quarters: 117 112 Although some projects from the strategic plan for 2020 are painful to 107 implement (e.g. Q1 Asian sales: -23% due to a change in the distribution 102 model), they are key to achieving accelerated sales and margin growth. Q1 97 negative factors will gradually wear off and the relaunch of Carrera 92 (March 2015) will be a major catalyst. Excluding the impact from Gucci in 87 2017, our estimates imply 14-17 CAGRs of 8% and 18%, for sales and Source Thomson Reuters EBIT, respectively. STOXX EUROPE 600 CONSUMER GDS E STOXX EUROPE 600 M&A: no large transactions ahead in our opinion. Following the failed merger talks between EI and LUX in 2013, we believe the same obstacles still exist (leadership conflicts, great operational complexity, and governance issues at Luxottica), especially as both groups have other significant, less risky medium-term growth drivers. In addition, we do not believe in the acquisition of SFL by EI since the licencing business does not seem to be of interest to EI and since this move would be a declaration of war on LUX. Therefore, we expect smaller acquisitions. Analyst: Consumer Analyst Team: Cédric Rossi Nikolaas Faes 33(0) 1 70 36 57 25 Loïc Morvan [email protected] Antoine Parison Virginie Roumage r r Optical & Eyewear Sector Table of contents 1. State of the global optical market in 2014 .............................................................................. 3 1.1. A market growing at a 4% rate ........................................................................................................ 3 1.2. The sunglasses market is still enjoying strong momentum! ....................................................... 4 1.2.1. The “Made in Italy” label is in good shape! .................................................................... 4 1.2.2. Solid medium-/long-term catalysts .................................................................................. 6 1.2.3. Essilor is also contributing to the premiumisation of the sunglasses segment ....... 10 1.3. Prescription lenses: a slightly more enabling environment ...................................................... 11 1.3.1. Economic conditions are gradually improving ............................................................. 12 1.3.2. Significant increase in marketing expenses to reinvigorate the high-end segment…13 1.3.3. … and the business in mature markets .......................................................................... 13 2. Lessons learned in Q1 15 ........................................................................................................ 15 2.1. US: still the main driver of the sector .......................................................................................... 15 2.2. Europe: the improvement that started in 2014 is taking hold ................................................. 16 2.3. Emerging countries: surprise in Latin America! ......................................................................... 17 3. Our estimates for 2015-17 ...................................................................................................... 19 3.1. Towards solid organic growth in 2015-17 ................................................................................... 19 3.1.1. Essilor’s strategy is firmly in place! ................................................................................. 19 3.1.2. Luxottica: the virtues of vertical integration ................................................................. 21 3.1.3. Safilo: towards profitable and, more importantly, sustainable growth! .................... 24 3.2. Higher profitability for everyone! ................................................................................................. 25 3.2.1. Essilor still has potential for margin improvement ..................................................... 25 3.2.2. Luxottica: operational leverage is still there! ................................................................. 26 3.2.3. Safilo: towards a gradual recovery of profitability........................................................ 27 3.3. A stimulating positive currency impact! ....................................................................................... 29 3.3.1. Revenues: the sector benefits from USD exposure ..................................................... 29 3.3.2. Profitability: transactional impact is an advantage for Luxottica .............................. 30 4. A combination of positive factors propping up stock prices ............................................ 31 4.1. Positive trend in stock prices in H1 15 ........................................................................................ 31 4.2. Current topics ................................................................................................................................... 32 4.2.1. Concerns over the French optical market? ................................................................... 32 4.2.2. M&A: small deals…? ......................................................................................................... 33 4.2.3. M&A: … or large mergers? .............................................................................................. 34 4.3. Valuation-to-growth profile ........................................................................................................... 38 4.4. DCF valuation .................................................................................................................................. 39 Essilor (BUY, FV EUR124) ......................................................................................................... 43 A wider playing field for new opportunities! .......................................................................................... 43 Luxottica (Buy, FV EUR63) ........................................................................................................ 45 All-Star Game Winner ................................................................................................................................ 45 Safilo (BUY vs. Neutral, FV EUR15) ........................................................................................ 46 Towards a more positive momentum ...................................................................................................... 46 Price Chart and Rating History ................................................................................................... 49 Bryan Garnier stock rating system .............................................................................................. 51 2 Optical & Eyewear Sector 1. State of the global optical market in 2014 1.1. A market growing at a 4% rate Euromonitor estimates that the global optical market grew by 4.2% in 2014 to EUR29.1bn (wholesale value excluding eye surgery equipment). Although this performance is similar to that of 2013, we observed an acceleration in the growth trend of the sunglasses & frame segment, which more than offset the slowdown of the reading glasses segment: (i) Corrective lenses: in 2014, this segment was up 3% to EUR11.2bn (+2% in 2013). According to our estimates, Essilor continued to gain market share (~44% in value terms vs. 42% in 2013 and ~39% in volume terms vs. 37% in 2013), whereas its two main rivals Hoya (Japan) and
Load more

Recommended publications
  • Essilorluxottica 28 May 2019 Update to Credit Analysis Following Affirmation of A2
    CORPORATES CREDIT OPINION EssilorLuxottica 28 May 2019 Update to credit analysis following affirmation of A2 Update Summary Following the mandatory tender offer, whereby EssilorLuxottica (the company or the group) acquired 93.3% of Luxottica's shares, the company subsequently launched a sellout and squeeze-out of the remaining shares for a combination of stock issuances and a cash consideration of about €640 million. As of March 5, 2019, EssilorLuxottica controlled all the RATINGS share capital of Luxottica, whose shares have been delisted from the Italian stock exchange. EssilorLuxottica Domicile France EssilorLuxottica's A2 rating continues to reflect (1) its position as the global leader in Long Term Rating A2 corrective lenses and eyewear market by a large margin to its competitors, illustrating the Type LT Issuer Rating - Fgn group's strong innovation capabilities and brand portfolio; (2) the group's wide offering Curr within its product category and its vertical integration, which allow it to cater to a variety Outlook Stable of customers and develop strong relationships with opticians; (3) a very solid track record Please see the ratings section at the end of this report of steady growth and resilient operating performance; and (4) the group's strong financial for more information. The ratings and outlook shown profile, underpinned by a healthy free cash flow (FCF) generation. reflect information as of the publication date. EssilorLuxottica's rating also factors in (1) the group's concentration of sales generated by its corrective lenses and frames business, as well as its relative concentration in the US market; Contacts (2) the still subdued economic environment in some of the group's key markets, which can Knut Slatten +33.1.5330.1077 weigh on lenses' renewal rates or result in some trading down by consumers; (3) the risk of a VP-Senior Analyst competitor making a breakthrough innovation; and (4) a degree of uncertainty around future [email protected] financial policies and the group's appetite for future external growth.
    [Show full text]
  • Group Vision Plans Simplicity That Makes You Smile
    1 Group Vision Plans Simplicity that makes you smile. Last updated 09/2018 On our quest to keep benefits outstanding and simple, we are also looking for easy ways for our brokers to enhance their business too. That’s why we offer a variety of uncomplicated vision plans. Vision plans that are effortless, highly valued and an easy way to enhance your client’s benefits package. They are quick to set up, take little administrative time and are painless to manage. So if you aren’t taking advantage of this simple way to expand your clientele, we think you should be. 01 Table of Contents 02 Why Dental Select 03 National Provider Access 04 Vision Health and Wellness 05 Financial Strength 06 Nationwide Availability 07 Dental Coverage 08 Online and On the Go Group Vision Plans 10 Vis-6 Vision Plan 11 Vis-8 Vision Plan 12 Vis-12 Vision Plan 13 Vis-21 Vision Plan 14 Vision Plan Comparison 15 Vision Plan Notes 16 Participation Requirements Vision Plan Forms 17 New Group Checklist 18 All Group Application 20 Employee Enrollment Form 22 Employee Change Form 27 Group EFT Authorization Form 28 Key Terms 29 FAQs 02 Why Dental Select? We know your clients will take notice of major retail brands like LensCrafters, Pearle Vision, JCPenney, Sears Optical, and Target Optical. Yeah, we’ve got all those. Plus, with the ability to order glasses and contacts online, your clients will easily see our commitment to service and simplicity. Day in and day out, our Dental Select family works hard to bring uncluttered, personable experiences and preferred benefits.
    [Show full text]
  • Stacking up the Top 50 Optical Retailers COVER TOPIC
    34 Stacking Up the Top 50 Optical Retailers COVER TOPIC Updated on 5/15/2019 VM’s Ranking Underscores Expansion Among the 10 Leading Players MARGE AXELRAD / SENIOR VP, EDITORIAL DIRECTOR AND MARK TOSH / SENIOR EDITOR U.S. Vision Care Market Mass (in millions) Merchants’ NEW YORK—New attitudes among consumers to- Top 50 Share Top 10 Share Share ward purchasing in general and the rise of digital $14,364.0* $12,561.7* $3,501.5* exploration and purchasing may have upended the general retail marketplace last year with many store closures and reorgs. But as the U.S. economy 40.2% 35.2% 9.8% held its own, the optical industry’s total sales rose just slightly and remained stable. It was new and continued private equity-driven investments in optical and optometric retail and solid organic sales growth from value-sector opti- Total 2018 Market: $35,725** cal retailers that reflected a higher dollar volume * VM Estimate ** Vision care products and services sold at optical retail locations. Source: VisionWatch | The Vision Council among the 50 U.S. Optical Retailers in Vision Mon- Data is from 12ME Dec. 2018 Continued on page 44 VM’s Top 50 Sales Concentration Grows Top 50 Retailers’ Sales (in millions) NEW YORK—There was a higher concentration of sales among the 2019 VM Top Mass Top 10 Share Merchants’ $12,561.7* 50 U.S. Optical Retailers, which assesses estimates of 12 months of calendar sales 24.4% Share 87.5% for the year ending Dec. 2018. The Top 10 optical retailers collectively comprise $3,501.5* 87.5 percent of the Top 50 U.S.
    [Show full text]
  • A Large Vision Network Means There's Always a Provider In
    Vision Plans Network Options A large vision network means there’s always a provider in sight. UnitedHealthcare knows how important it is to find a provider you can trust who meets your lifestyle, eye care and eyewear needs. With our large national eye care network, Spectera Eyecare Networks, you can choose to get more personalized care from a private practice. Or, take advantage of the convenience retail chains offer with evening and weekend hours. Either way, we’re focused on providing you with a better eye care experience. Well-known practices and brands in our large national network include: • 20/20 Vision Center • Eye Boutique • 3 Guys Optical • EyeCare Associates • AccurateOptical • Eye Express • All About Eyes • eyecarecenter Making it easier for you • Allegany Eyecare • Eyeglass World to find a provider. • America’s Best • EyeMart Express To find the provider who best • Bard Optical • Eyetique meets your needs, login to • BJ’s Optical • For Eyes myuhcvision.com or call • Boscov’s Optical • General Vision Services 1-800-638-3120. • Clarkson Eyecare • H. Rubin Vision Centers Some providers or locations may not participate in your plan. • Co/Op Optical • Henry Ford OptimEyes • Cohen’s Fashion Optical • Horizon Eye Care • Costco Optical • Houston Eye Associates • Crown Vision Center • JC Penney Optical • Dr. Travel Family Eye Care • Midwest Vision Centers CONTINUED • MyEyeDr. • Standard Optical • National Optometry • Stanton Optical • National Vision • Sterling Optical • Nationwide Vision • SVS Vision • NUCROWN • Target Optical (not available for • Optical Shop at Meijer all members) • Optyx • Texas State Optical • Ossip Optometry • The Eye Gallery • Pearle Vision • The Hour Glass • Rosin Eyecare • Thoma & Sutton Optical • RX Optical • Today’s Vision • Sam’s Club • Virginia Eye Institute • Schaeffer Eye Centers • Vision4Less • Sears Optical (not available for • Visionmart Express all members) • Visionworks • See Inc.
    [Show full text]
  • LUXOTTICA BUY the Short-Sighted Shouldn’T Panic PRESENT PRICE: €10.70 TARGET PRICE: €13.50 INITIATION of COVERAGE
    European Equity Research Italy – Household Goods and Textiles Madrid, June 12, 2003 LUXOTTICA BUY The Short-sighted Shouldn’t Panic PRESENT PRICE: €10.70 TARGET PRICE: €13.50 INITIATION OF COVERAGE Carlo Scomazzoni Nathalie Longuet-Saleur Tousette Yvonne Edwards (34) 91-701-9432 (33) 1-5353-7435 (49) 69-91507-357 [email protected] [email protected] [email protected] Luxottica is the world’s leading manufacturer and Basic Figures, June 11, 2003 retailer of mid- and premium-priced sunglasses and Reuters / Bloomberg codes: LUX.MI / LUX IM prescription frames, with a turnover of €3bn. 73% of Market capitalisation (€ mn): 4,825 sales are made in the US, where the company controls Number of shares (mn): 452.1 the two leading retail chains in their respective Average daily volume (€ mn): 3.1 52-week range (€): 20.20-9.25 segments: LensCrafters and Sunglass Hut International. Free float (%): 25.0 Ray-Ban is Luxottica’s most important proprietary 2003E ROE (%): 18.4 brand, while licensed brands include Chanel, Versace, 2003E P/BV (x): 3.1 Bvlgari and other luxury brands. 2002-04F PEG: Neg Source: Reuters and SCH Bolsa estimates and forecasts. The eyewear market has grown steadily over the past Estimates and Fundamental Ratios 10-to-15 years, as glasses have gradually come to be 2001 2002 2003E 2004F considered fashion accessories. Luxottica has been able Net profit (€ mn): 316.4 372.1 283.4 308.1 to outpace market growth thanks to its fully-integrated % change: 23.9 17.6 -23.8 8.7 business model and well executed acquisitions.
    [Show full text]
  • Visioncare Plan
    visioncare plan What to expect from your vision plan: Your eyesight is nothing to take for granted. It’s how we see a loved one’s face clearly or a beautiful sunset. But your sight can begin to deteriorate over a long period of time without your knowing there is a problem. No claims to file! As with any other important asset – like your home or car – wouldn’t you feel Just show your more at ease if you knew your routine eye care was covered by a company with VisionCare Plan decades experience helping people like you? With CompBenefits’ VisionCare ID card Plan, you can take advantage of coverage you need for eye examinations and eyeglasses or contacts. You can also choose to take advantage of VisionCare Plan’s deep discount for LASIK surgery. And you won’t have to hunt hard to find a doctor close to your home or work. The VisionCare Plan network includes some 14,000 ophthalmologist and optometrist locations – one third of all private practitioners in the country. Yet, it doesn’t mean you can’t see an out-of-network doctor because VisionCare Plan offers benefits in-network or out-of-network. It’s your choice. You’ll find what you need @ www.mycompbenefits.com CompBenefits has made understanding and accessing your VisionCare Plan benefits simple. Just take a few moments to register at www.mycompbenefits.com. SSVCP Orange County Sheriff’s Office Open your eyes to high-quality vision care! The average family spends close to $600 each year on routine eye health care.
    [Show full text]
  • Consent Solicitation: Approval of the Transfer of the Notes from Luxottica to Essilorluxottica
    NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO THE UNITED STATES, OR TO ANY PERSON LOCATED OR RESIDENT IN, ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO RELEASE, PUBLISH OR DISTRIBUTE THIS DOCUMENT Consent solicitation: approval of the transfer of the Notes from Luxottica to EssilorLuxottica Charenton-le-Pont, France (November 26, 2019 – 6:00 pm) – Further to the press release dated 24 October 2019, Luxottica Group S.p.A. (“Luxottica”) and EssilorLuxottica S.A. (“EssilorLuxottica”) announce that in relation to the Euro 500,000,000 2.625 per cent. fixed rate notes due 10 February 2024 (ISIN: XS1030851791) issued by Luxottica in 2014 (the "Notes"), the meeting of the holders of the Notes today approved the transfer of the Notes from Luxottica to EssilorLuxottica, the release of the guarantors under the Notes, and certain modifications to the conditions of the Notes, all as further described in the Consent Solicitation Memorandum dated 24 October 2019, a copy of which is available under the “Consent solicitation” section on Luxottica’s website at http://www.luxottica.com/en/investors/consent-solicitation. Luxottica and EssilorLuxottica draw the attention of the holders of the Notes that as described in the Consent Solicitation Memorandum, the transfer will be effective as from the Implementation Date. ### EssilorLuxottica EssilorLuxottica is a global leader in the design, manufacture and distribution of ophthalmic lenses, frames and sunglasses. Formed in 2018, its mission is to help people around the world to see more, be more and live life to its fullest by addressing their evolving vision needs and personal style aspirations.
    [Show full text]
  • Form 20-F. in 2016
    UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F (Mark One) អ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ፤ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2016 OR អ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 OR អ SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 1-10421 LUXOTTICA GROUP S.p.A. (Exact name of Registrant as specified in its charter) (Translation of Registrant’s name into English) REPUBLIC OF ITALY (Jurisdiction of incorporation or organization) PIAZZALE L. CADORNA 3, MILAN 20123, ITALY (Address of principal executive offices) Michael A. Boxer, Esq. Executive Vice President and Group General Counsel Piazzale L. Cadorna 3, Milan 20123, Italy Tel: +39 02 8633 4052 [email protected] (Name, Telephone, Email and/or Facsimile Number and Address of Company Contact Person) Securities registered or to be registered pursuant to Section 12(b) of the Act. Title of each class Name of each exchange of which registered ORDINARY SHARES, PAR VALUE NEW YORK STOCK EXCHANGE EURO 0.06 PER SHARE* AMERICAN DEPOSITARY NEW YORK STOCK EXCHANGE SHARES, EACH REPRESENTING ONE ORDINARY SHARE * Not for trading, but only in connection with the registration of American Depositary Shares, pursuant to the requirements of the New York Stock Exchange Securities registered or to be registered pursuant to Section 12(g) of the Act.
    [Show full text]
  • Luxottica Admitted to the Cooperative Compliance Scheme with the Italian Revenue Agency
    Luxottica admitted to the Cooperative Compliance scheme with the Italian Revenue Agency Milan, 29 December 2020 – Luxottica was admitted by the Italian Revenue Agency to the Cooperative Compliance scheme under legislative decree no. 128/2015. The aim of the Cooperative Compliance scheme, in accordance with current legislation to prevent tax risk and permit a further increase in the level of certainty regarding important fiscal matters, is to strengthen the relationship of trust and transparency between Luxottica and the Italian Revenue Agency. The admission to the scheme was preceded by an assessment performed by the Revenue Agency examining the full adequacy of Tax Governance and the Tax Control Framework adopted by Luxottica for the detection, measurement, management, and control of potential tax risk. Adherence to this regime is part of a wider Luxottica strategy aimed at the preventative management of risk based on transparency with financial administrations at a global level for the benefit of all stakeholders. Contacts: Oriana Pagano Group Corporate Media Relations Manager Email: [email protected] Luxottica Group S.p.A. About Luxottica Group Luxottica is a leader in the design, manufacture and distribution of fashion, luxury and sports eyewear. Its portfolio includes proprietary brands such as Ray-Ban, Oakley, Costa, Vogue Eyewear, Persol, Oliver Peoples and Alain Mikli, as well as licensed brands including Giorgio Armani, Burberry, Bulgari, Chanel, Coach, Dolce&Gabbana, Ferrari, Michael Kors, Prada, Ralph Lauren, Tiffany & Co., Valentino and Versace. The Group’s global wholesale distribution network covers more than 150 countries and is complemented by an extensive retail network of approximately 9,000 stores, with LensCrafters and Pearle Vision in North America, OPSM, LensCrafters and Spectacle Hut in Asia -Pacific, GMO and Óticas Carol in Latin America, Salmoiraghi & Viganò in Italy and Sunglass Hut worldwide.
    [Show full text]
  • Teamcare Eyemed - Vision Care Why It Will Cost You More with the Trustee Chosen Teamster Provider
    Teamcare EyeMed - Vision Care why it will cost you more with the trustee chosen Teamster Provider Teamsters Mandatory $15.63 a month Vision Plan is no benefit. 1. Luxottica and EyeMed Monopoly from Italy brought to you by Teamcare “A consumer-level frame costs significantly less than $10 to manufacture. The rest is operations, licensing and profit. Think about that the next time you pick up an average $150 frame. These aren’t markedly different or superior to the $30 glasses available from reputable online dealers — and those include lenses, probably the same ones you were just about to pay $200 for in the store.” A key to the industry-standard overpricing is the fact that a single corporation — Luxottica, the world’s largest eyewear firm — owns many retail eyewear chains and many popular eyewear brands. Based in Milan, Italy, Luxottica owns and operates LensCrafters, Sears Optical, Target Optical, Pearle Vision, Sunglass Hut, Ilori, and other chains in the United States, along with yet more chains throughout Asia, Europe, Africa, India, the Antipodes and the Middle East. Luxottica owns Ray-Ban, Oakley, Oliver Peoples, Vogue, and other brands, and makes glasses under license for over a dozen designer labels including Versace, Prada, Bulgari, DKNY, Burberry, Ralph Lauren, Dolce & Gabbana, Donna Karan, Tiffany, and more. As if that isn’t enough, Luxottica is also the parent company of a vision-care benefits program, EyeMed. Eyewear prices in brick-and-mortar stores stay artificially high, Mitchell says, due to “the lack of real competition, inasmuch as Luxottica owns massive manufacturing, licensing, retailing and insurance interests” — albeit EyeMed is “not so much insurance as a marketing ploy to get people to buy from their stores at a discount and to force the remaining independent stores to buy Luxottica controlled frames.
    [Show full text]
  • Professional Providers Near You
    Professional Providers Near You Please note: not all providers offer all services. Please confirm what services are offered with the provider. COHEN'S FASHION OPTICAL LENSCRAFTERS 330 W 42ND ST MANHATTAN MALL NEW YORK, NY 10036 901 AVE OF AMERICAS STE 205MAILBOX 104 (212)594-2831 NEW YORK, NY 10001 0.2 Miles (212)967-4166 0.4 Miles COHENS FASHION OPTICAL LENSCRAFTERS 1450 BROADWAY SIXTH AVE AND 26TH ST NEW YORK, NY 10018 776 SIXTH AVE (212)719-1391 NEW YORK, NY 10001 0.3 Miles (212)481-2001 0.7 Miles PENN OPTICAL GROUP LENSCRAFTERS 450 SEVENTH AVESTE 207 530 BUILDING NEW YORK, NY 10123 542 FIFTH AVE (212)279-4826 NEW YORK, NY 10036 0.3 Miles (212)302-4882 0.7 Miles MACYS VISION EXPRESS LENSCRAFTERS 151 W 34TH ST 44TH ST AND LEXINGTON AVE NEW YORK, NY 10001 425 LEXINGTON AVE (212)494-7300 NEW YORK, NY 10017 0.4 Miles (212)922-2929 1.0 Miles EUROPEAN OPTICAL CORP LENSCRAFTERS 33 W 32ND ST 6 E 23RD ST NEW YORK, NY 10001 NEW YORK, NY 10010 (212)971-0911 (212)982-7850 0.6 Miles 1.0 Miles SIGHT IMPROVEMENT CTR INC LENSCRAFTERS 25 W 43RD STSTE 316 1804 BROADWAY NEW YORK, NY 10036 NEW YORK, NY 10019 (212)921-1888 (212)262-1502 0.6 Miles 1.0 Miles WESTSIDE VISION ASSOCIATES LENSCRAFTERS 156 W 28TH STREET CORNER OF 5TH AVE & 20TH NEW YORK, NY 10001 150 FIFTH AVE (212)244-5536 NEW YORK, NY 10011 0.6 Miles (212)352-1460 1.1 Miles SUNY COLLEGE OF OPTOMETRY LENSCRAFTERS 33 W 42ND ST 777 THIRD AVE NEW YORK, NY 10036 777 THIRD AVE (212)938-4001 NEW YORK, NY 10017 0.6 Miles (212)527-2363 1.1 Miles EYES ON MADISON LENSCRAFTERS 197 MADISON AVENUE 510 SIXTH
    [Show full text]
  • Fielmann Ag Company Report
    MASTER IN FINANCE FIELMANN AG COMPANY REPORT EUROPEAN EYEWEAR RETAIL 4 JANUARY 2021 STUDENT: JAN-PHILIP JANSEN [email protected] Fashionable Glasses for Everyone Recommendation: BUY Fielmann Strengthens its Position in the Industry Price Target FY21: 79.01 € Price (as of 3-Jan-21) 66.45 € Our recommendation is to BUY Fielmann AG considering a Bloomberg: FIE target price of €79.01 as of 31.12.2021 reflected in an upside potential of 20.69% (thereof €1.19 expected dividend) to the current 52-week range (€) 41.90-76.25 Market Cap (€m) 5,581 share price of €66.45. Outstanding Shares (m) 84,000 Source: Thomson Reuters EIKON Market trends like an ever aging population, digitalization and industry consolidation set a solid foundation for further sustainable growth. We think Fielmann will be able to re-accelerate top-line growth back to 5%, achieved by a consistent realization of Fielmann’s corporate strategy “Vision 2025”. High Liquidity and strong Free Cash Flows provide sufficient funding for the renovation and internationalization Source: Yahoo Finance strategy. (Values in € millions) 2019 2020E 2021F The COVID-19 pandemic is currently the biggest threat for Revenues 1,524 1,385 1,556 the eyewear industry but at the same time a huge opportunity for EBITDA 410 328 382 EBIT 281 178 244 Fielmann due to its strong financial position. In contrast to other Capex 185 155 215 analysts, we expect Fielmann to be one of the post-crisis winners. FCF 126 118 68 Source: Annual Report 2019, Analyst Estimation We believe that the broad market might underestimate future profitabilty arising from further market consolidation.
    [Show full text]